Butyric Acid Market Size and Share
Butyric Acid Market Analysis by Mordor Intelligence
The butyric acid market stands at 54.98 kilotons in 2025 and is projected to reach 77.37 kilotons by 2030, reflecting a healthy 7.07% CAGR during 2025-2030. Rising demand for specialty feed additives, clean-label flavors, and bio-based chemicals sustains volume growth, while advances in fermentation and microencapsulation technologies widen profit pools. Asia-Pacific drives expansion through large livestock populations and chemical manufacturing capacity, holding a 38.77% share in 2024. Animal feed remains the leading and fastest advancing application, which underscores the shift toward antibiotic-free nutrition practices. Near-term volatility in petrochemical feedstocks still clouds cost visibility, but vertical integration and precision-fermentation pilots give producers strategic options to manage risk.
Key Report Takeaways
- By source, synthetic production accounted for 62.17% of the butyric acid market share in 2024, while renewable routes are projected to expand at 8.89% CAGR through 2030.
- By grade, food grade led with 40.60% share in 2024, whereas pharmaceutical grade is forecast to post a 9.03% CAGR during 2025-2030.
- By application, animal feed held 38.32% of the butyric acid market size in 2024 and is set to grow at 9.54% CAGR to 2030.
- By geography, Asia-Pacific commanded 38.77% share of the butyric acid market in 2024, and the region is expected to progress at an 8.06% CAGR over the forecast window.
Global Butyric Acid Market Trends and Insights
Driver Impact Analysis
| Drivers | (~) % Impact on Market CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Growing Utilization for Animal Feed Additives | +2.5 | Global, with emphasis on Asia-Pacific | Medium term (≈3-4 yrs) |
| Increasing Demand as a Flavoring Agent and Preservative | +1.2 | North America & Europe | Short term (≤2 yrs) |
| Rising Demand from the Pharmaceutical Industry | +1.0 | Global | Medium term (≈3-4 yrs) |
| Growing Demand for Gut Health and Probiotic Products | +1.8 | North America & Europe, with spillover to Asia-Pacific | Short term (≤2 yrs) |
| Increase in Adoption in Europe due to Carbon Taxes | +0.8 | Europe | Long term (≥5 yrs) |
| Source: Mordor Intelligence | |||
Growing Utilization for Animal Feed Additives
Producers continue positioning the butyric acid market as a cornerstone of antibiotic-free nutrition programs. Protected calcium butyrate improved duodenal villus height and antibody titers in poultry trials, confirming its role in gut integrity and immune modulation. Microencapsulation overcomes odor issues and delivers the acid to lower intestinal sections, which supports premium pricing strategies in Asia’s poultry and swine hubs. Tributyrin, coated sodium butyrate, and microencapsulated formulations offer unique release profiles aligning with species-specific digestive transit. Integration of butyric acid into low-zinc and reduced-antibiotic diets strengthens cost-of-gain metrics for large integrators, while regulatory curbs on prophylactic antibiotics accelerate inclusion rates in Europe and, increasingly, Latin America.
Increasing Demand as Flavoring Agent and Preservative
Butyric acid derivatives such as butyl butyrate contribute cheese-like, fruity, and fermented notes that are difficult to replicate. Food manufacturers pair the molecule’s flavor attributes with its antimicrobial properties to extend shelf life in clean-label yogurts and plant-based cheeses. North American bakeries have adopted liquid butyrate blends that reduce mold without synthetic preservatives, aligning with non-GMO labeling trends. Flavor houses are deploying bio-fermentation to match natural labeling rules in the European Union, thereby hedging against the bloc’s stringent flavor-ingredient directives. Taste enhancement and microbial inhibition convergence differentiate butyric acid from substitute esters, sustaining margin resilience in the butyric acid market.
Rising Demand from Pharmaceutical Industry
Clinical data validates the therapeutic promise of butyrate in metabolic and gastrointestinal disorders. A 1.5 g/day oral sodium butyrate regimen lowered gastrointestinal symptom scores and small intestinal bacterial overgrowth in type 2 diabetes patients[1]Radwa Eladwy, “Postbiotic Sodium Butyrate Synergizes Dexamethasone,” Frontiersin.org, frontiersin.org. In a separate double-blind trial, butyrate improved liver parameters and lipid profiles in adults with steatosis and metabolic syndrome. These outcomes have encouraged contract development organizations to scale pharmaceutical-grade butyric acid under stringent impurity limits. Formulation advances include gastro-resistant capsules that bypass the stomach to reach the colon, enhancing bioavailability. Small-molecule combinations, such as sodium butyrate with dexamethasone, have shown synergistic antiproliferative effects on gastric adenocarcinoma cell lines[2]Paulina Panufnik, “Effect of Butyrate on GI Signs, SIBO, and Diabetes Control,” Diabetesjournals.org, diabetesjournals.org. As intellectual-property filings rise, the butyric acid market benefits from high-value, low-volume demand that supports premium capacity investments.
Growing Demand for Gut Health and Probiotic Products
Consumer interest in microbiome balance fuels retail uptake of butyrate-fortified supplements. NutraShure launched a tasteless, ready-to-mix ingredient that simplifies inclusion in powdered beverages, broadening channel access through online specialty retailers. Epidemiological findings presented at ECCMID 2024 linked a 10% rise in butyrate-producing bacteria with a 14-25% drop in infection-related hospitalizations, reinforcing consumer willingness to pay a premium for preventive care. Brand owners respond with delayed-release capsules and triglyceride oils such as SunButyrate-TG liquid, which support gut barrier integrity and bowel motility. Retail analytics show steady SKU expansion in the United States vitamin aisle, confirming that functional claims resonate with health-conscious adults. These dynamics enhance downstream pull for producers in the butyric acid market.
Restraint Impact Analysis
| Restraints | (~) % Impact on Market CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Volatility in Raw Material Prices | -1.5 | Global | Short term (≤2 yrs) |
| Availability of Viable Alternatives | -0.9 | Global | Medium term (≈3-4 yrs) |
| Technical and Process Challenges | -1.2 | Global, with emphasis on renewable production | Medium term (≈3-4 yrs) |
| Source: Mordor Intelligence | |||
Volatility in Raw Material Prices
The conventional oxidation route relies on butyraldehyde derived from petrochemical propylene. Shipping disruptions and crude swings widened price bands in 2024 and early 2025, squeezing margins for producers weighted toward synthetic supply. Flexible producers hedge exposure by securing alternative aldehyde supplies and by converting part of their capacity to fermentation lines. South-east Asian players seek long-term propylene contracts with integrated crackers to limit spot-price risk. These tactics partially buffer input shocks yet do not eliminate earnings volatility across the butyric acid market.
Availability of Viable Alternatives
Certain synthetic esters and propionic acid blends can replicate antimicrobial functions in sauces and bakery glazes at a lower price point. Flavor chemists also deploy hexanoate esters to mimic dairy notes in cost-sensitive markets, eroding demand for butyl butyrate in mainstream applications. These substitutes force continuous innovation in encapsulation, purity, and natural-label positioning. Market participants diversify with expanded grade portfolios, including pharmaceutical, feed, and perfumery, to reduce over-reliance on vulnerable flavor volumes inside the butyric acid market.
Segment Analysis
By Source: Renewable Production Gains Momentum
Synthetic material dominated the butyric acid market size with 62.17% share in 2024 due to an entrenched oxo-alcohol infrastructure. Renewable volumes, however, are forecast to post an 8.89% CAGR as stricter carbon-pricing regimes push buyers toward low-emission incumbents. Innovations such as microbial electrosynthesis and precision-fermentation reduce energy intensity and allow waste-CO₂ feedstocks, positioning renewable supply as a viable hedge against propylene volatility.
Volume-driven feed integrators in Southeast Asia secure renewable forward contracts to improve sustainability scores on export meat labels. European flavor houses negotiate green-premium price formulas indexed to ETS allowances, ensuring renewable butyric acid retains a differential yet affordable position. Such procurement strategies tighten offtake agreements, granting early movers a competitive edge. If microbial electrosynthesis reaches targeted operating costs, renewable suppliers could account for a third of the butyric acid market share by the mid-2030s.
Note: Segment shares of all individual segments available upon report purchase
By Grade: Pharmaceutical Applications Accelerate Growth
Food grade maintained the widest footprint in 2024, fueled by dairy flavorings and shelf-life extension. The pharmaceutical segment advances at a 9.03% CAGR on the back of clinical successes in metabolic and gastrointestinal disorders. This tier demands stringent impurity profiles, pushing producers to adopt ion-exchange polishing and closed-loop solvent recovery. Contract research organizations expand analytical packages for endotoxin and short-chain acid quantification, facilitating regulatory submissions. Food grade retains consistent growth, backed by rising processed dairy consumption in India and cheese seasoning demand in the United States.
Industrial grade applications leverage butyric acid as a chemical intermediate in plastics and mining reagents. These uses remain steady but face decarbonization pressures that may shift formulations toward greener substitutes. Overall, differential growth widens the value gap, enabling pharmaceutical producers to enjoy higher EBITDA margins inside the butyric acid market.
By Application: Animal Feed Dominates Growth Trajectory
Animal feed captured 38.32% of the butyric acid market share in 2024 and is projected to compound at 9.54% until 2030. Strong evidence on gut-health enhancement and antibiotic-reduction drives inclusion in starter diets across Asia-Pacific mega-farms. Feed premix firms bundle butyrate with phytase and essential oils to create multi-functional additives that command premium pricing. The food and flavor segment stays resilient as plant-based dairy alternatives gain traction and require authentic taste masking.
Perfumes capitalize on the fruity notes of butyrate derivatives, though limited volume keeps the segment niche. Emerging research on upgrading waste carboxylic acids to sustainable aviation fuel introduces a long-tail upside for industrial application, yet commercialization lies beyond the current forecast horizon. These dynamics cement animal feed as the anchor customer for the butyric acid market and set the pace for capacity planning.
Note: Segment shares of all individual segments available upon report purchase
Geography Analysis
Asia-Pacific dominated the butyric acid market in 2024 with a 38.77% share, underpinned by China’s chemical clusters and India’s fast-growing dairy and poultry sectors. Regional demand aligns with national mandates to curb antibiotic usage, prompting feed millers to integrate high-load butyrate premixes in broiler and layer rations. The region is forecast to expand at an 8.06% CAGR through 2030 as integrated livestock conglomerates upgrade biosecurity and gut-health programs.
Advanced pharmaceutical formulations and a robust nutraceutical sector drive North America. Clinical research universities collaborate with specialty-chemical firms on colon-targeted delivery platforms, funneling grant funding into early-stage trials. Regulatory clarity on Generally Recognized as Safe (GRAS) filings accelerates flavor adoption in plant-based cheese substitutes. This stable policy environment supports mid-single-digit growth across the butyric acid market.
Europe’s trajectory diverges as carbon-pricing policies influence sourcing patterns. Importers face a rising cost floor for petrochemical-based acid, prompting a procurement shift toward renewable supply. Local producers invest in carbon-capture and utilization integration, aiming to capitalize on EU funding schemes that incentivize circular chemistry. These moves position Europe as a future hub for bio-based butyric acid production.
South America and the Middle-East, and Africa remain smaller contributors yet display potential. Brazil’s poultry exports to the Gulf Cooperation Council bloc encourage biosecurity upgrades, including butyrate additive programs. South Africa’s dairy processors introduce clean-label preservatives to meet upscale retail standards. Infrastructure constraints temper rapid acceleration, but strategic alliances with multinational feed companies could unlock latent demand within the butyric acid market.
Competitive Landscape
The butyric acid market exhibits a relatively high concentration, dominated by integrated chemical majors and a cohort of specialized feed-additive firms. These players pursue incremental capacity debottlenecking and differentiated product offerings, such as odor-masked powders and triglyceride oils, to maintain share. Emerging entrants emphasize precision fermentation and microbial electrosynthesis to deliver low-carbon solutions. Several startups partner with cement producers to capture CO₂ streams and convert them into butyrate, challenging incumbents on sustainability metrics.
Butyric Acid Industry Leaders
-
Eastman Chemical Company
-
Merck
-
OXEA GmbH
-
Perstorp
-
Snowco
- *Disclaimer: Major Players sorted in no particular order
Recent Industry Developments
- January 2025: Kemin industries, Inc., launched ButiShield in Europe after securing EU approval for its antioxidant system, marking the firm’s first controlled-release butyrate additive targeted at companion-animal nutrition.
- January 2025: Perstorp increased the price of its butyric acid in January. The company cited escalating costs as the primary reason behind the price increase.
Research Methodology Framework and Report Scope
Market Definitions and Key Coverage
Our study defines the global butyric acid market as commercial-grade straight-chain C4 fatty acid produced through synthetic oxo routes or renewable fermentation, sold in liquid form above 96 % purity for use in feed additives, food flavors, chemical intermediates, perfumes, and regulated pharmaceutical preparations.
Scope exclusion: Salts and esters (for example, sodium, calcium, or ethyl butyrate), isobutyric acid, and captive in-house consumption are purposely left outside the sizing to maintain a clean like-for-like baseline.
Segmentation Overview
- By Source
- Renewable Butyric Acid
- Synthetic Butyric Acid
- By Grade
- Food Grade
- Industrial Grade
- Pharmaceutical Grade
- By Application
- Chemical Intermediates
- Animal Feed
- Pharmaceuticals
- Perfumes
- Food and Flavors
- Other Applications (Biofuel, Cosmetics, etc.)
- By Geography
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Rest of Europe
- South America
- Brazil
- Argentina
- Rest of South America
- Middle-East and Africa
- Saudi Arabia
- South Africa
- Rest of Middle-East and Africa
- Asia-Pacific
Detailed Research Methodology and Data Validation
Primary Research
Mordor analysts interviewed animal-nutrition formulators across China, Germany, and Brazil, specialty chemical distributors in the US Gulf Coast, and fermentation technology suppliers in Japan. These dialogues clarified typical inclusion rates, current average selling prices (ASP), utilization levels at new bio-based plants, and regional demand triggers. Findings were looped back into the desk-research grid to close data gaps.
Desk Research
We began with production and trade statistics from UN Comtrade, FAO feed balance sheets, and Eurostat PRODCOM to map supply flows and end-use footprints. Process economics and capacity data were pulled from USITC propylene reports, Asia Metal refinery bulletins, and company 10-Ks. These were then sanity-checked against patent families in Questel and news archives in Dow Jones Factiva. Regulatory context, such as the EU ban on growth-promoter antibiotics, came from EFSA and USDA GAIN notices. The listings above illustrate, but do not exhaust, the secondary sources mined for trend lines and base metrics.
Market-Sizing & Forecasting
A top-down capacity-utilization build starts with nameplate synthetic and renewable output by plant, subtracts captive use, and matches the balance against verified trade plus modeled domestic demand pools. We corroborate results with bottom-up signals such as sampled ASP × volume from channel checks and feed-mill inclusion audits, adjusting totals where variances exceed 7 %. Key variables include global broiler and swine feed tonnage, propylene feedstock prices, fermentation yield improvements, average inclusion rates in antibiotic-free diets, and regulatory milestone dates. A multivariate regression links these drivers to historic uptake. Scenario analysis then extends forecasts to 2030. Gaps where supplier roll-ups are opaque are bridged using regional import parity pricing and three-year moving-average ASPs.
Data Validation & Update Cycle
Outputs pass a two-step peer review, followed by variance checks against independent price dashboards and customs tallies. Reports refresh annually; interim updates are triggered by >=10 % capacity additions, material policy shifts, or ASP swings beyond one standard deviation. A final analyst pass occurs before each client delivery.
Why Our Butyric Acid Baseline Earns Industry Trust
Published figures often diverge because firms pick dissimilar chemical scopes, ASP assumptions, and refresh cadences.
According to Mordor Intelligence, we stick to neat butyric acid only, report the first fully post-pandemic year (2025), and blend volume with live ASP inputs. Others fold in derivatives, apply constant prices, or anchor older base years.
Benchmark comparison
| Market Size | Anonymized source | Primary gap driver |
|---|---|---|
| 54.98 KT (2025) | Mordor Intelligence | - |
| USD 317 M (2022) | Global Consultancy A | Includes isobutyric acid and derivatives; outdated base year; no primary validation |
| USD 422 M (2025) | Trade Journal B | Uses constant ASPs across regions; omits pharmaceutical uptake |
| USD 263 M (2024) | Regional Consultancy C | Excludes China and India demand; single-source desk research |
These contrasts show why our carefully delimited scope, blended price-volume model, and yearly refresh provide decision-makers with the most balanced, reproducible benchmark available.
Key Questions Answered in the Report
What is the current size of the butyric acid market?
The butyric acid market size stands at 54.98 kilotons in 2024, reflecting strong multi-industry demand.
Which segment shows the fastest growth in the butyric acid industry?
Animal feed remains the fastest-growing application, with a 9.54 % forecast CAGR for 2025-2030 due to antibiotic-free production trends.
How quickly is pharmaceutical-grade butyric acid expanding?
Pharmaceutical-grade volumes are projected to rise at a 9.03 % CAGR through 2030, fuelled by clinical evidence in metabolic and gut disorders.
Why is Europe important for renewable butyric acid?
Carbon pricing mechanisms such as CBAM and EU ETS 2 incentivize bio-based routes, making Europe a launchpad for commercial renewable plants.
What challenges affect renewable production of butyric acid?
Fermentation faces issues like substrate inhibition and downstream purification costs, though advances in metabolic engineering are easing these constraints.
Page last updated on: